| 1 |
33820651 | PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls. | 2021 Sep |
1 |
| 2 |
34126466 | Regional relationships between CSF VEGF levels and Alzheimer's disease brain biomarkers and cognition. | 2021 Sep |
1 |
| 3 |
33076977 | FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels. | 2020 Oct 19 |
1 |
| 4 |
30610252 | Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease. | 2019 May |
1 |
| 5 |
31642932 | Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults. | 2019 Oct 2 |
1 |
| 6 |
29066367 | Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study. | 2018 Jan 1 |
4 |
| 7 |
29268078 | Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. | 2018 May |
2 |
| 8 |
28900724 | Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease. | 2017 Nov |
1 |
| 9 |
26836192 | Posterior Accumulation of Tau and Concordant Hypometabolism in an Early-Onset Alzheimer's Disease Patient with Presenilin-1 Mutation. | 2016 |
2 |
| 10 |
25646706 | Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study. | 2015 May |
1 |
| 11 |
19433663 | Preclinical evidence of Alzheimer changes: convergent cerebrospinal fluid biomarker and fluorodeoxyglucose positron emission tomography findings. | 2009 May |
1 |
| 12 |
19822868 | Relationships between biomarkers in aging and dementia. | 2009 Oct 13 |
3 |
| 13 |
18395614 | CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. | 2008 May 15 |
2 |